Deutsche Cannabis ROE 2024

Deutsche Cannabis Aktienanalyse

What does Deutsche Cannabis do?

The German Cannabis AG is a rising company that specializes in the production and sale of medical cannabis. The company was founded in 2018 and is headquartered in Frankfurt am Main. The history of the German Cannabis AG began when a group of investors came together to invest in the growing market for medical cannabis. They recognized the potential that cannabis has as a medical product and the growing demand for high-quality cannabis. The founders of the company made it their mission to breed the best hemp varieties and extract the active ingredients in order to deliver the highest possible quality to their customers. The business model of the German Cannabis AG is based on growing and distributing medical cannabis. The company has its own plantation in Portugal, where it grows cannabis in modern greenhouses. The cultivation area is currently around 30 hectares and is planned to be expanded in the future. The company is committed to meeting the highest quality standards and therefore relies on state-of-the-art technologies and processes. For example, only organic-certified seeds are used to ensure optimal quality and purity of the end product. The German Cannabis AG offers various divisions to meet the different needs of customers. These divisions include not only medical cannabis but also CBD products, cosmetics, and dietary supplements. In the medical cannabis division, the company seeks to provide doctors and patients with high-quality and reliable products. The individual needs and specific requirements are the main focus. The company produces various products such as oils, capsules, flowers, or extracts that are tailored to the needs of patients. These products are sold exclusively to pharmacies and are available by prescription only. The CBD products division includes oils, cosmetics, and dietary supplements based on cannabidiol (CBD). These products are legal and can be purchased online or in specialty stores without a prescription. The company also places great emphasis on quality and reliability in this division and conducts intensive research and development. The cosmetics division includes various products such as creams, ointments, and balms based on medical cannabis. These are specifically offered for the treatment of skin problems such as eczema, psoriasis, or skin inflammation. Natural ingredients are used, and synthetic products are avoided. The dietary supplements division is characterized by high-quality products such as capsules, powders, or oils enriched with medical cannabis. These products support the immune system, digestion, and overall vitality of the body. In summary, the German Cannabis AG is a rising company specializing in the production and sale of medical cannabis and related products. Quality and reliability are the focus, and intensive investment is made in research and development. The different divisions offer customers a wide range of products that are individually tailored to their needs. Deutsche Cannabis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Deutsche Cannabis's Return on Equity (ROE)

Deutsche Cannabis's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Deutsche Cannabis's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Deutsche Cannabis's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Deutsche Cannabis’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Deutsche Cannabis stock

What is the ROE (Return on Equity) of Deutsche Cannabis this year?

The ROE of Deutsche Cannabis this year is 0 undefined.

How has the Return on Equity (ROE) of Deutsche Cannabis developed compared to the previous year?

The ROE of Deutsche Cannabis has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Deutsche Cannabis?

A high ROE indicates that Deutsche Cannabis generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Deutsche Cannabis?

A low ROE can indicate that Deutsche Cannabis is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Deutsche Cannabis affect the company?

A change in ROE (Return on Equity) of Deutsche Cannabis can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Deutsche Cannabis?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Deutsche Cannabis?

Some factors that can influence Deutsche Cannabis's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Deutsche Cannabis pay?

Over the past 12 months, Deutsche Cannabis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deutsche Cannabis is expected to pay a dividend of 0 EUR.

What is the dividend yield of Deutsche Cannabis?

The current dividend yield of Deutsche Cannabis is .

When does Deutsche Cannabis pay dividends?

Deutsche Cannabis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deutsche Cannabis?

Deutsche Cannabis paid dividends every year for the past 0 years.

What is the dividend of Deutsche Cannabis?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deutsche Cannabis located?

Deutsche Cannabis is assigned to the 'Communication' sector.

Wann musste ich die Aktien von Deutsche Cannabis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deutsche Cannabis from 12/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Deutsche Cannabis pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Deutsche Cannabis in the year 2023?

In the year 2023, Deutsche Cannabis distributed 0 EUR as dividends.

In which currency does Deutsche Cannabis pay out the dividend?

The dividends of Deutsche Cannabis are distributed in EUR.